Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Iain Moore

Iain Moore

At university, Iain Moore spent time deciphering nuclear magnetic resonance spectra to determine the atomic structure of organometallic products that he had synthesized. It was an inspiring and captivating area, but didn’t satisfy his need to apply the knowledge to real world problems. “A career in industry – predominantly with the oleochemical supplier Croda – put all my problem solving skills to the test.” Combining these skills with the desire to help people do better led him naturally to quality assurance, and then to working internationally on the definition of best practice standards for pharmaceutical excipients and now bio-based products. “Along the way, I like to think I’ve helped solve one or two real world problems.”

  • Contributions

The Long Road to EXCiPACT

November 7, 2014

If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started? A good question! But, actually, I have no regrets; the story of EXCiPACT and its impact, even today, on the pharmaceutical industry makes every second worthwhile.

0 min read

The Long Road to EXCiPACT

Quality, Not Quantity

July 8, 2019

Qualitative risk assessments are a great way to approach quality management and train your operators at the same time.

0 min read

Quality, Not Quantity

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.